Möhlig M - Search Results

1

Association between adiponectin and mediators of inflammation in obese women.

Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, Möhlig M, Pfeiffer AF, Luft FC, Sharma AM. Engeli S, et al. Among authors: mohlig m. Diabetes. 2003 Apr;52(4):942-7. doi: 10.2337/diabetes.52.4.942. Diabetes. 2003. PMID: 12663465

2

Adiponectin and protection against type 2 diabetes mellitus.

Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Spranger J, et al. Among authors: mohlig m. Lancet. 2003 Jan 18;361(9353):226-8. doi: 10.1016/S0140-6736(03)12255-6. Lancet. 2003. PMID: 12547549

3

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.

Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Spranger J, et al. Among authors: mohlig m. Diabetes. 2003 Mar;52(3):812-7. doi: 10.2337/diabetes.52.3.812. Diabetes. 2003. PMID: 12606524

4

Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.

Spranger J, Möhlig M, Wegewitz U, Ristow M, Pfeiffer AF, Schill T, Schlösser HW, Brabant G, Schöfl C. Spranger J, et al. Among authors: mohlig m. Clin Endocrinol (Oxf). 2004 Dec;61(6):738-46. doi: 10.1111/j.1365-2265.2004.02159.x. Clin Endocrinol (Oxf). 2004. PMID: 15579189

5

Changes of adiponectin oligomer composition by moderate weight reduction.

Bobbert T, Rochlitz H, Wegewitz U, Akpulat S, Mai K, Weickert MO, Möhlig M, Pfeiffer AF, Spranger J. Bobbert T, et al. Among authors: mohlig m. Diabetes. 2005 Sep;54(9):2712-9. doi: 10.2337/diabetes.54.9.2712. Diabetes. 2005. PMID: 16123361

6

Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21.

Mai K, Andres J, Biedasek K, Weicht J, Bobbert T, Sabath M, Meinus S, Reinecke F, Möhlig M, Weickert MO, Clemenz M, Pfeiffer AF, Kintscher U, Spuler S, Spranger J. Mai K, et al. Among authors: mohlig m. Diabetes. 2009 Jul;58(7):1532-8. doi: 10.2337/db08-1775. Epub 2009 Apr 28. Diabetes. 2009. PMID: 19401423 Free PMC article.

7

Acute hyperinsulinaemia and hyperlipidaemia modify circulating adiponectin and its oligomers.

Bobbert T, Weicht J, Mai K, Möhlig M, Pfeiffer AF, Spranger J. Bobbert T, et al. Among authors: mohlig m. Clin Endocrinol (Oxf). 2009 Oct;71(4):507-11. doi: 10.1111/j.1365-2265.2008.03519.x. Clin Endocrinol (Oxf). 2009. PMID: 19751297

8

The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity.

Arafat AM, Weickert MO, Frystyk J, Spranger J, Schöfl C, Möhlig M, Pfeiffer AF. Arafat AM, et al. Among authors: mohlig m. J Clin Endocrinol Metab. 2009 Dec;94(12):5093-101. doi: 10.1210/jc.2009-0875. Epub 2009 Oct 21. J Clin Endocrinol Metab. 2009. PMID: 19846739

9

Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians.

Bobbert T, Schwarz F, Fischer-Rosinsky A, Pfeiffer AF, Möhlig M, Mai K, Spranger J. Bobbert T, et al. Among authors: mohlig m. Diabetes Care. 2013 Jan;36(1):145-9. doi: 10.2337/dc12-0703. Epub 2012 Aug 28. Diabetes Care. 2013. PMID: 22933429 Free PMC article.

10

Insulin decreases human adiponectin plasma levels.

Möhlig M, Wegewitz U, Osterhoff M, Isken F, Ristow M, Pfeiffer AF, Spranger J. Möhlig M, et al. Horm Metab Res. 2002 Nov-Dec;34(11-12):655-8. doi: 10.1055/s-2002-38248. Horm Metab Res. 2002. PMID: 12660877 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters